Pharmaids Pharmaceuticals submits audited financial results

21 May 2022 Evaluate

Pharmaids Pharmaceuticals has informed that it enclosed the Audited Financial Results for the Quarter and Year ended March 31, 2022 along with the Auditor’s Report thereon, issued by the Statutory Auditors on Audited Financial Results and the Declaration, as required in terms of SEBI Circular No. CIR/CFD/CMD/56/2016 dated May 27, 2016. The said Financial Results have been approved by the Board of Directors of the Company at their Meeting held today May 21, 2022.

The above information is a part of company’s filings submitted to BSE.

Pharmaids Pharma Share Price

53.98 4.90 (9.98%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.